TA
TFG Advisers’s Pfizer PFE Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q4 | – | Sell |
-6,319
| Closed | -$210K | – | 205 |
|
2023
Q3 | $210K | Buy |
6,319
+518
| +9% | +$17.2K | 0.1% | 184 |
|
2023
Q2 | $213K | Buy |
5,801
+419
| +8% | +$15.4K | 0.1% | 188 |
|
2023
Q1 | $220K | Buy |
5,382
+21
| +0.4% | +$857 | 0.11% | 186 |
|
2022
Q4 | $275K | Sell |
5,361
-62
| -1% | -$3.18K | 0.14% | 155 |
|
2022
Q3 | $237K | Buy |
5,423
+57
| +1% | +$2.49K | 0.13% | 165 |
|
2022
Q2 | $281K | Buy |
5,366
+34
| +0.6% | +$1.78K | 0.15% | 149 |
|
2022
Q1 | $276K | Buy |
5,332
+88
| +2% | +$4.56K | 0.13% | 163 |
|
2021
Q4 | $310K | Sell |
5,244
-22
| -0.4% | -$1.3K | 0.14% | 157 |
|
2021
Q3 | $226K | Buy |
+5,266
| New | +$226K | 0.11% | 187 |
|
2020
Q1 | – | Sell |
-5,292
| Closed | -$207K | – | 362 |
|
2019
Q4 | $207K | Buy |
+5,292
| New | +$207K | 0.12% | 161 |
|
2019
Q3 | – | Sell |
-5,954
| Closed | -$257K | – | 163 |
|
2019
Q2 | $257K | Buy |
5,954
+467
| +9% | +$20.2K | 0.18% | 131 |
|
2019
Q1 | $233K | Buy |
5,487
+88
| +2% | +$3.74K | 0.17% | 138 |
|
2018
Q4 | $235K | Buy |
+5,399
| New | +$235K | 0.2% | 131 |
|